These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23484527)

  • 1. Drug target discovery using retroviruses.
    Blø M; Micklem DR; Lorens JB
    Expert Opin Drug Discov; 2007 Oct; 2(10):1285-300. PubMed ID: 23484527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemogenomics approaches to novel target discovery.
    Gaither LA
    Expert Rev Proteomics; 2007 Jun; 4(3):411-9. PubMed ID: 17552925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of mammalian cells stably expressing multiple genes at predetermined levels.
    Liu X; Constantinescu SN; Sun Y; Bogan JS; Hirsch D; Weinberg RA; Lodish HF
    Anal Biochem; 2000 Apr; 280(1):20-8. PubMed ID: 10805516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of retroviral vectors and helper cells for gene therapy.
    Hu WS; Pathak VK
    Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vector-based RNAi approaches for stable, inducible and genome-wide screens.
    Fewell GD; Schmitt K
    Drug Discov Today; 2006 Nov; 11(21-22):975-82. PubMed ID: 17055406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense and RNAi: powerful tools in drug target discovery and validation.
    Lavery KS; King TH
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
    Tolmachov O
    Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral vector targeting for gene therapy.
    Günzburg WH; Fleuchaus A; Saller R; Salmons B
    Cytokines Mol Ther; 1996 Sep; 2(3):177-84. PubMed ID: 9384702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of peptides in Diogenesis: a novel approach to drug discovery and phenomics.
    Blume AJ; Beasley J; Goldstein NI
    Biopolymers; 2000; 55(4):347-56. PubMed ID: 11169925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral vectors for liver-directed gene therapy.
    Kalpana GV
    Semin Liver Dis; 1999; 19(1):27-37. PubMed ID: 10349681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets.
    Vogt A; Lazo JS
    Pharmacol Ther; 2005 Aug; 107(2):212-21. PubMed ID: 15925410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral microarray-based platform on nanostructured TiO2 for functional genomics and drug discovery.
    Carbone R; Giorgetti L; Zanardi A; Marangi I; Chierici E; Bongiorno G; Fiorentini F; Faretta M; Piseri P; Pelicci PG; Milani P
    Biomaterials; 2007 Apr; 28(13):2244-53. PubMed ID: 17276506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How will RNAi facilitate drug development?
    Bartz S; Jackson AL
    Sci STKE; 2005 Aug; 2005(295):pe39. PubMed ID: 16077085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging field of chemical genetics: potential applications for pesticide discovery.
    Walsh TA
    Pest Manag Sci; 2007 Dec; 63(12):1165-71. PubMed ID: 17912687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritizing hits from phenotypic high-content screens.
    Low J; Stancato L; Lee J; Sutherland JJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):338-45. PubMed ID: 18428087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
    Federici T; Boulis NM
    Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of gene expression by siRNA in hematopoietic cells.
    Scherr M; Eder M
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):262-9. PubMed ID: 15782549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.